Figure 4 shows that treatment of the cells with gigantol significantly suppressed CD133 and ALDH1A1 expressions in a dose-dependent manner, confirming that gigantol suppresses CSCs phenotypes in lung cancer cells. Here, PROM1 is linked to lung cancer.